Growing Market Presence BOL Pharma operates in the expanding medical cannabis industry in Israel with a strong history since 2007, demonstrating established credibility and growth opportunities in pharmaceutical and wellness sectors worldwide.

Full Vertical Integration The company sources 99% pharma-grade cannabinoids from its own organic, GMP-certified cultivation and production facilities, ensuring consistent quality and supply chain reliability for potential partners seeking high-quality active ingredients.

Diverse Client Base Opportunity BOL Pharma serves a broad range of clients including physicians, HMOs, and medical centers, indicating substantial potential to expand into pharmaceutical, food, supplement, and cosmetic markets seeking cannabinoid-based formulations.

Innovative R&D Capabilities With extensive research experience and manufacturing for clinical research, BOL Pharma is positioned to collaborate on new product development, offering opportunities to partner on innovative cannabinoid products and APIs.

Strategic Growth & Investment Having secured notable funding of $30M and a revenue range of up to $25M, BOL Pharma is poised for further expansion, making it a promising partner for investors and suppliers looking to participate in a dynamic and growing market.